About
Technology
Issues
FAQ
Links
Official Page
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first‐line gefitinib, erlotinib and afatinib‐treated non‐small cell lung cancer patients with activating EGFR mutations
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.